<code id='3073458DE3'></code><style id='3073458DE3'></style>
    • <acronym id='3073458DE3'></acronym>
      <center id='3073458DE3'><center id='3073458DE3'><tfoot id='3073458DE3'></tfoot></center><abbr id='3073458DE3'><dir id='3073458DE3'><tfoot id='3073458DE3'></tfoot><noframes id='3073458DE3'>

    • <optgroup id='3073458DE3'><strike id='3073458DE3'><sup id='3073458DE3'></sup></strike><code id='3073458DE3'></code></optgroup>
        1. <b id='3073458DE3'><label id='3073458DE3'><select id='3073458DE3'><dt id='3073458DE3'><span id='3073458DE3'></span></dt></select></label></b><u id='3073458DE3'></u>
          <i id='3073458DE3'><strike id='3073458DE3'><tt id='3073458DE3'><pre id='3073458DE3'></pre></tt></strike></i>

          Home / explore / entertainment

          entertainment


          entertainment

          author:explore    Page View:47
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In